Healthcare expenditures and increasing antimicrobial consumption in Turkey

Basit Öğe Kaydı
dc.contributor.authorHosoglu, Salih
dc.contributor.authorKarabay, Oguz
dc.date.accessioned2024-04-24T17:14:47Z
dc.date.available2024-04-24T17:14:47Z
dc.date.issued2012
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjectives: The aim of this study was to assess the trend in antimicrobial consumption in Turkey between 2007 and 2010. Methods: Antimicrobial consumption data were obtained from Intercontinental Medical Statistics Turkey office. The total antimicrobial consumption data were calculated as Defined Daily Dose (DDD)/1000 inhabitant-days. The correlation between the previous five-year period and association with the main indicators of economy and healthcare services of the country were assessed. Results: Total utilization of antibiotics increased from 33.7 to 38.8 DDD/1000 inhabitant-days between 2007 and 2010. A steady increase took place during the study period. When this period was compared with the previous period (between 2001 and 2006), a similar trend was found. Turkey's total healthcare expenditure 2001 to 2010 increased from 4.5 billion Turkish Liras to 32 billion Turkish Liras. Conclusion: In Turkey, antibiotic consumption increased steadily in recent years, with a close relation to government healthcare support policy, rising health expenditures and other economical indicators.en_US
dc.identifier.doi10.1179/1973947812Y.0000000040
dc.identifier.endpage347en_US
dc.identifier.issn1120-009X
dc.identifier.issn1973-9478
dc.identifier.issue6en_US
dc.identifier.pmid23174099
dc.identifier.scopus2-s2.0-84870842485
dc.identifier.scopusqualityQ3
dc.identifier.startpage344en_US
dc.identifier.urihttps://doi.org/10.1179/1973947812Y.0000000040
dc.identifier.urihttps://hdl.handle.net/11468/18194
dc.identifier.volume24en_US
dc.identifier.wosWOS:000311489000004
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofJournal of Chemotherapy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntibiotic Policyen_US
dc.subjectAntibacterial Drug Screening Policyen_US
dc.subjectAntimicrobial Agentsen_US
dc.subjectAntimicrobial Resistance Surveillanceen_US
dc.titleHealthcare expenditures and increasing antimicrobial consumption in Turkeyen_US
dc.titleHealthcare expenditures and increasing antimicrobial consumption in Turkey
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu